Cargando…

Editorial: Cancer Treatment and Early Detection Targeting HER Receptors

Detalles Bibliográficos
Autores principales:	Cai, Xiaoqing, Zhang, Libing, Chen, Shengxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240762/ https://www.ncbi.nlm.nih.gov/pubmed/35782870 http://dx.doi.org/10.3389/fmolb.2022.940055

Ejemplares similares

Editorial: Cancer treatment and early detection targeting HER receptors, Volume II
por: Cai, Xiaoqing, et al.
Publicado: (2023)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
por: Chen, Dong, et al.
Publicado: (2021)

Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine
por: Miladinova, Daniela
Publicado: (2023)

Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers
por: Yu, Jinfeng, et al.
Publicado: (2022)

Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
por: Xu, Yi, et al.
Publicado: (2023)

Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers
por: Zheng, Yang, et al.
Publicado: (2023)

Editorial: “Small molecules targeting transmembrane receptors and ion channels in drug discovery”
por: Vitale, Rosa Maria, et al.
Publicado: (2023)

Editorial: Novel advances in gastrointestinal cancer treatment
por: Liu, Yanqing, et al.
Publicado: (2023)

Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways
por: Suraweera, Amila, et al.
Publicado: (2022)

Mass Spectrometry-Based Targeted Serum Monomethylated Ribonucleosides Profiling for Early Detection of Breast Cancer
por: Fang, Zhihao, et al.
Publicado: (2021)

Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy
por: Zhang, Lan, et al.
Publicado: (2023)

Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis
por: Dasari, Subramanyam, et al.
Publicado: (2023)

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Editorial: Primary cilia as therapeutic targets
por: Nishimura, Yuhei, et al.
Publicado: (2023)

Editorial: Molecular Diagnostics in the Detection of Neurodegenerative Disorders
por: Agrawal, Megha, et al.
Publicado: (2017)

Editorial: Targeting glioblastoma: Mechanisms of pathology and novel therapeutic strategies
por: Kusaczuk, Magdalena, et al.
Publicado: (2023)

Editorial: Ferroptosis in cancer and beyond
por: Wang, Xin, et al.
Publicado: (2023)

Editorial: The DNA Replication Machinery as Therapeutic Targets
por: Gardner, Andrew F., et al.
Publicado: (2019)

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
por: Kumar, Vinay, et al.
Publicado: (2023)

Editorial: Role of the SUMOylation in cancer regulation
por: Chen, Xu, et al.
Publicado: (2023)

Editorial: Molecular Insights Into Ligand-Receptor Interactions on the Cell Surface
por: Marchetti, Laura, et al.
Publicado: (2022)

Editorial: Transient receptor potential channels (TRP): signal transduction
por: Dietrich, Alexander, et al.
Publicado: (2023)

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers
por: Fusco, Nicola, et al.
Publicado: (2023)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms
por: Ye, Yanting, et al.
Publicado: (2022)

Editorial: Interactions Between Small Molecule Ligands and Target Enzymes
por: Kim, Sung-Kun, et al.
Publicado: (2021)

Editorial: Peptides Targeting Protein-Protein Interactions: Methods and Applications
por: Belvisi, Laura, et al.
Publicado: (2021)

Editorial: Ferroptosis in cancer and Beyond—volume II
por: Wang, Xin, et al.
Publicado: (2023)

Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer
por: Rui, Tao, et al.
Publicado: (2022)

Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer
por: Sivasubramanian, Maharajan, et al.
Publicado: (2014)

Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer
por: Bandini, Erika, et al.
Publicado: (2021)

Editorial: Computational Solutions for Microbiome and Metagenomics Sequencing Analyses
por: Reza, Md. Selim, et al.
Publicado: (2021)

Editorial: Biology and Pharmacological Effects of Extracellular Vesicles in Cancer
por: Zhang, Jian-ye, et al.
Publicado: (2022)

Editorial: Molecular Targeted Therapy in Oncology: Lessons From Pharmacogenetics and Pharmacoepigenetics
por: Imani, Saber, et al.
Publicado: (2022)

Editorial: Advances in the therapeutic targeting of human matrix metalloproteinases in health and disease
por: Bharadwaj, Shiv, et al.
Publicado: (2023)

Editorial: Bioengineered Nanoparticles in Cancer Therapy
por: Zarrintaj, Payam, et al.
Publicado: (2021)

Editorial: Heterogeneity and plasticity of prostate cancer
por: Culig, Zoran, et al.
Publicado: (2023)

Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
por: Sajjadi, Elham, et al.
Publicado: (2023)

Editorial: Application of Systems Biology in Molecular Characterization and Diagnosis of Cancer
por: Zhang, Cheng, et al.
Publicado: (2021)

Editorial: Computational solutions for microbiome and metagenomics sequencing analyses, Volume II
por: Niyogisubizo, Jovial, et al.
Publicado: (2023)

Editorial: NAD+ metabolism as a novel target against infection–Volume II
por: Balducci, Enrico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rb6mtecg9o2fdo2dv7n2c3dbc2